CLOs on the Move


 
KoKo, LLC is a global respiratory information systems software developer and medical device manufacturing company. The exclusive provider of Iris™, the world`s first Integrated Respiratory Information System; and KoKo® pulmonary function testing, diagnostic spirometry, and respiratory home monitoring devices. Our expert, scalable software solutions and sophisticated data collection products empower healthcare providers to advance respiratory diagnostic processes and improve patient outcomes while meeting the demanding clinical and business objectives of thought leaders in respiratory care.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.kokopft.com
  • 1200 S Fordham Street Suite B
    Longmont, CO USA 80503
  • Phone: 720.640.4222

Executives

Name Title Contact Details

Similar Companies

Zee Medical Service

Zee Medical Service is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Create Orthotics and Prosthetics

Create O&P offers intuitive 3D printing and digital solutions to orthotists and prosthetists worldwide. We provide the tools, training, and support for O&P practices to incorporate digital workflows into their current patient care. Modernizing your practice creates stress. We create solutions.

Tibion Bionic Technologies

Tibion Bionic Technologies is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.

Sovereign Medical Service

Sovereign Medical Services (SMS “The Company” is a leader in the fast-growing Medical Ancillary Services within the health care industry. SMS provides the health care professional: management expertise, and investment opportunities in multiple Medical Surgical services. It also provides expertise in managing primary care and multi-specialty practices, with the State of Art information technology systems. These ancillaries are high quality, profitable, cost effective services.

Novadaq

Enabling surgeons with clinically-relevant, innovative fluorescence imaging solutions to enhance the lives of patients and their surgeons, while reducing health care costs, is Novadaq’s global mission. SPY fluorescence imaging technology provides surgeons with real-time visualization, leading to improved outcomes and reduced costs without exposing the patient to harmful ionizing radiation or contrast dye toxicity. More than 130 peer-reviewed publications demonstrate that the use of SPY during complex surgery, leads to fewer post-operative complications and lower hospital costs. The SPY Imaging System is United States Food and Drug Administration (“FDA”) 510(k) cleared for use in seven surgical specialties. The endoscopic version of SPY called PINPOINT®, combines the capabilities of SPY Imaging with high definition (“HD”) visible light visualization offered by conventional endoscopes. Our unique business model of partnering with market-leading companies to drive adoption of our fluorescence imaging technology, while building our own commercial infrastructure is the cornerstone of our corporate strategy for growth.